TCRSEQ Trademark

Trademark Overview


On Tuesday, April 24, 2018, a trademark application was filed for TCRSEQ with the United States Patent and Trademark Office. The USPTO has given the TCRSEQ trademark a serial number of 87891560. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 1, 2019. This trademark is owned by Adaptive Biotechnologies. The TCRSEQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific res...
tcrseq

General Information


Serial Number87891560
Word MarkTCRSEQ
Filing DateTuesday, April 24, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDevelopment of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineering

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 3, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Monday, April 1, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 1, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 21, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 21, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 14, 2018ASSIGNED TO EXAMINER
Thursday, May 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 27, 2018NEW APPLICATION ENTERED IN TRAM